Novel Concepts in Vascular Stent Design: Can Stent be Personalized Through Computational Fluid Dynamics?

Publisher： Bentham Science Publishers

E-ISSN： 1875-6913|12|4|183-187

ISSN： 1875-6921

Source： Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol.12, Iss.4, 2014-12, pp. : 183-187

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current Concepts on Cardiovascular Stent Devices

By  

Mini Reviews in Medicinal Chemistry, Vol. 14, Iss. 6, 2014-05 ,pp. : 505-536

Bentham Science Publishers

Access to resources Recommend Favorite

The Intra-Vascular Stent as a Site-Specific Local Drug Delivery System

By Khan Imran Ahmad   Patravale Vandana  

Drug Development and Industrial Pharmacy, Vol. 31, Iss. 1, 2005-01 ,pp. : 59-78

Informa Healthcare

Access to resources Recommend Favorite

Can Angiotensin Receptor Antagonists Prevent Restenosis After Stent Placement?

By Peters S.  

American Journal of Cardiovascular Drugs, Vol. 2, Iss. 3, 2002-01 ,pp. : 143-148

Adis International

Access to resources Recommend Favorite

Rationale and study design of the CardioGene Study: genomics of in-stent restenosis

By Ganesh Santhi K   Skelding Kimberly A   Mehta Laxmi   O’Neill Kathleen   Joo Jungnam   Zheng Gang   Goldstein James   Simari Robert   Billings Eric   Geller Nancy L   Holmes David   O’Neill William W   Nabel Elizabeth G  

Pharmacogenomics, Vol. 5, Iss. 7, 2004-10 ,pp. : 949-1004

Future Medicine

Access to resources Recommend Favorite

Rapamycin can Inhibit the Development of Chlamydia pneumoniae, which Might Partly Contribute to the Prevention of In-stent Restenosis

By Yan Ying   Silvennoinen-Kassinen Sylvi   Leinonen Maija   Saikku Pekka  

Cardiovascular Drugs and Therapy, Vol. 24, Iss. 3, 2010-06 ,pp. : 189-195

Springer Publishing Company

Access to resources Recommend Favorite